Hodgkin's Lymphoma
Research & Clinical Trials
Dana-Farber Cancer Institute is a founding member of a small national consortium of leading medical centers that investigates new treatments for children with Hodgkin's disease. Through this consortium, Dana-Farber/Children's Hospital Cancer Care (DF/CHCC) physicians are investigating new drug combinations that deliver good results with fewer long-term complications. Currently, we are accruing patients for a research study investigating treatment for low-risk and advanced Hodgkin's disease.
In addition, DF/CHCC offers access to all Children's Oncology Group's Phase I clinical trials and other trials for relapsed Hodgkin's.
If you are interested in learning about our clinical trials, visit our online listing or contact our New Patient Coordinator at (888) PEDI-ONC (888-733-4662) .
